Extensive investigation of benzylic N-containing substituents on the pyrrolopyrimidine skeleton as Akt inhibitors with potent anticancer activity
作者:Yang Liu、Zhen Zhang、Fansheng Ran、Kaiwen Guo、Xin Chen、Guisen Zhao
DOI:10.1016/j.bioorg.2020.103671
日期:2020.4
Continuous optimization of benzylic substituents on 1-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazin-1-yl)-2-phenylethan-1-one structure as Akt inhibitors was described in this paper. Particularly, compounds 8 and 14g exhibited high enzymatic potency against all Akt isoforms and antiproliferative effects in mantle cell lymphoma cell lines, as well as favorable cytotoxicities in patient primary cancer
本文描述了1-(4-(7H-吡咯并[2,3-d]嘧啶-4-基)哌嗪-1-基)-2-苯基乙-1-酮结构上作为Akt抑制剂的苄基取代基的连续优化纸。特别地,化合物8和14g显示出针对所有Akt同种型的高酶促效力和在套细胞淋巴瘤细胞系中的抗增殖作用,以及在患者原发性癌细胞中的有利细胞毒性。低微摩尔剂量的8g和14g剂量依赖性地诱导细胞凋亡和G2 / M细胞周期停滞,也抑制了Akt下游靶点GSK3β和S6的磷酸化水平。